PMV Pharmaceuticals, Inc. Net Income Loss

• PMV Pharmaceuticals, Inc. showed a decrease of -32.4% in Net Income Loss from 2024 to 2025.
• This data is from PMV Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), PMV Pharmaceuticals, Inc.'s Net Income Loss has declined by 343.3%.
• Historical annual values: Fiscal year 2025: -$77.74 million | Fiscal year 2024: -$58.71 million | Fiscal year 2023: -$68.96 million | Fiscal year 2022: -$73.32 million | Fiscal year 2021: -$57.85 million | Fiscal year 2020: -$34.44 million | Fiscal year 2019: -$25.35 million | Fiscal year 2018: -$17.54 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026